Abstract:Objective: Mucopolysaccharidosis type II (Hunter syndrome) is a rare X-linked recessive lysosomal storage disorder caused by the deficiency of the enzyme iduronate-2-sulfatase (IDS). Mutations of the IDS gene which is located on Xq27.3-q28 have been identified as responsible of Hunter syndrome or mucopolysaccharidosis type II. We’d like to investigate and establish the gene diagnosis methods for IDS gene in mucopolysaccharidosis type II patients. Design: Obtain the genomic DNA of patients and his parents, amplify with PCR, and analyse the PCR product with PCR-SSCP. Directly sequence the PCR product with abnomal band in PCR-SSCP. At last restriction enzyme digestions are used to verlify the result of DNA sequencing. Materials and Methods: Determination of carrier status in families, affected by this disorder has been performed using a number of biochemical tests. PCR amplification on genomic DNA of patients and his parents. PCR-SSCP analysis was applied to detect the mutations of exons which were amplificated in PCR. DNA sequencing and PCR-restriction enzyme digestion were applied to analyze the mutation which has been detect by PCR-SSCP. computer programs were necessary to elucidate the nature of the mutations. Results: Abnormal band in exon 7 and 9 of the IDS gene were found by applying PCR-SSCP; Two new alterations at the IDS locus, the mutation 1253 GμT of exon7 and the mutation 1672 CμT of exon9, were found in the two patients through DNA sequencing, The PCR-restriction enzyme digestion showed that enzyme digestion locations changed in the patients and their mothers, Which verified the results of sequencing analysis. Conclusion: To date, none of the available enzymatic tests have been shown to identify accurately 100% of obligate carriers. DNA testing provides an opportunity to identify carriers unambiguously. Combined applications of PCR-SSCP analysis, DNA sequencing analysis and PCR-restriction enzyme digestion can screen and diagnose MPS a effectively, quickly and perform easily. And information of detected mutations are potentially useful for the genotype-phenotype correlation, prognosis, possible therapeutic intervention, prenatal diagnosis and preimplantation genetic diagnosis of the pedigree.

The diagnosis and management of mucopolysaccharidosis type II

Phenotypic and genetic characteristics of 130 patients with mucopolysaccharidosis type II: A single-center retrospective study in China

Clinical characteristics and genotypes of 201 patients with mucopolysaccharidosis type II in China: A retrospective, observational study.

A Basic Understanding of Mucopolysaccharidosis: Incidence, Clinical Features, Diagnosis, and Management.

A Basic Understanding Of Mucopolysaccharidosis: Incidence, Clinical Features, Diagnosis, And Management

A Novel Iduronate 2-Sulfatase Mutation in a Chinese Family with Mucopolysaccharidosis Type II

Detailed Pedigree Analyses and Prenatal Diagnosis for a Family with Mucopolysaccharidosis Type II.

[Molecular Analysis of IDS Gene and Prenatal Diagnosis in a Chinese Family with Mucopolysaccharidosis Type II].

[Enzymatic Diagnosis of 47 Cases with Mucopolysaccharidosis].

Current status and progress of mucopolysaccharidosis type Ⅰ

Mucopolysaccharidosis type IIIC in chinese mainland: clinical and molecular characteristics of ten patients and report of six novel variants in the HGSNAT gene

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology

Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants

[Prenatal Diagnosis of Mucopolysaccharidosis Type II].

Diagnosis of Hunter syndrome: identification of iduronate-2-sulfatase gene mutations in patients with mucopolysaccharidosis type II in Chinese

Identification and characterization of novel genetic variants in the first Chinese family of mucopolysaccharidosis IIIC (Sanfilippo C syndrome)

Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan

A novel mutation of IDS gene in a Chinese patient with mucopolysaccharidosis II by next-generation sequencing

Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment

Clinical manifestations and genetic mutation analysis of patients with mucopolysaccharidosis type VII in China

Mucopolysaccharidosis III: Molecular basis and treatment